Tetra Discovery Partners LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
27
About the Report
About the Report
Summary
Tetra Discovery Partners LLC (Tetra Discovery) is a drug development company that researches and develops pharmaceutical drugs based on phosphodiesterase (PDE) sub-type inhibitors for neuroscience and non-neuroscience disorders. The company uses structure-guided drug design chemistry approach to discover allosteric inhibitors of phosphodiesterase 4 subtypes such as PDE4B and PDE4D. Its PDE4B drug is developed for treating various neuroinflammation and traumatic brain injury. Tetra Discovery also offers drugs for the treatment of depression and schizophrenia, Alzheimer's disease, other dementias, traumatic brain injury, psychiatric diseases, and neurodevelopmental disorders. The company partners with various universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system. Tetra Discovery is headquartered in Grand Rapids, Michigan, the US.
Tetra Discovery Partners LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Tetra Discovery Partners LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Tetra Discovery Partners Raises USD6 Million in Venture Financing 10
Tetra Discovery Partners Raises USD5 Million in Series A Venture Financing 11
Tetra Discovery Partners Raises USD4.3 Million in Venture Financing 12
Tetra Discovery Raises USD1 Million in Venture Financing 13
Tetra Discovery Raises Funds through Venture Financing 14
Tetra Discovery Raises USD0.3 Million in Venture Financing 15
Tetra Discovery Raises USD 1 Million In Seed Financing 16
Partnerships 17
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 17
Tetra Discovery Partners LLC-Key Competitors 18
Tetra Discovery Partners LLC-Key Employees 19
Tetra Discovery Partners LLC-Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jan 17, 2017: Tetra Discovery Partners appoints vice president of clinical operations 21
Product News 22
01/17/2017: Tetra Discovery Partners Appoints Richard Erwin as Vice President, Clinical Operations 22
Product Approvals 23
Apr 03, 2018: FDA Grants Orphan Drug Designation for Tetra Discovery Partners BPN14770 for the Treatment of Fragile X Syndrome 23
Clinical Trials 24
Mar 15, 2018: Tetra Discovery Partners Announces FDA Clearance of IND for Phase 2 Trial of BPN14770 in Fragile X Syndrome 24
Nov 07, 2017: New Preclinical Research Suggests Utility of Tetra Discovery Partners' BPN14770 to Provide Therapeutic Benefit in Fragile X Syndrome 25
Nov 06, 2017: Tetra Discovery Partners Research Supports Ability of Novel Selective PDE4D Inhibitor, BPN14770, to Improve Memory and Cognition 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Figure
List of Figures
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Key Facts 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetra Discovery Partners LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tetra Discovery Partners Raises USD6 Million in Venture Financing 10
Tetra Discovery Partners Raises USD5 Million in Series A Venture Financing 11
Tetra Discovery Partners Raises USD4.3 Million in Venture Financing 12
Tetra Discovery Raises USD1 Million in Venture Financing 13
Tetra Discovery Raises Funds through Venture Financing 14
Tetra Discovery Raises USD0.3 Million in Venture Financing 15
Tetra Discovery Raises USD 1 Million In Seed Financing 16
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 17
Tetra Discovery Partners LLC, Key Competitors 18
Tetra Discovery Partners LLC, Key Employees 19
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.